Sandostatin LAR

( DrugBank: - / KEGG DRUG: - )


4 diseases
IDDisease name (Link within this page)Number of trials
67Polycystic kidney disease1
77Growth hormone secreting pituitary adenoma40
IDDisease name (Link within this page)Number of trials
84Sarcoidosis1
193Prader-Willi syndrome2

67. Polycystic kidney disease


Clinical trials : 233Drugs : 188 - (DrugBank : 54) / Drug target genes : 60 - Drug target pathways : 165 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

77. Growth hormone secreting pituitary adenoma


Clinical trials : 351Drugs : 241 - (DrugBank : 28) / Drug target genes : 26 - Drug target pathways : 87 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

84. Sarcoidosis


Clinical trials : 175Drugs : 189 - (DrugBank : 80) / Drug target genes : 74 - Drug target pathways : 177 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

193. Prader-Willi syndrome


Clinical trials : 128Drugs : 94 - (DrugBank : 25) / Drug target genes : 51 - Drug target pathways : 102 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries